Wednesday, October 15, 2008
6:30pm – 8:30pm
|
DINNER SYMPOSIUM
Targeting Triglycerides and HDL-C:
Optimal Strategies
for Reducing Residual Cardiovascular Risk
Christie Ballantyne, MD; Michael Davidson, MD; Jorge Plutzky, MD
Supported by an educational grant from Abbott
|
Thursday, October 16, 2008
6:30am – 7:45am
|
BREAKFAST SYMPOSIUM
The Role of Direct Renin Inhibition in Cardiometabolic
Risk Reduction:
A State-of-the-Science Symposium
and Case-Based Discussion
Alan Gradman, MD; Marc Pfeffer, MD, PhD; Matthew Weir, MD
Supported by an educational grant from Novartis |
12:15pm – 1:30pm
|
LUNCH SYMPOSIUM
Management of Obesity, Type 2 Diabetes, and
Cardiovascular Disease:
A Role for CB1 Blockade?
Louis Aronne, MD; Christopher Cannon, MD; Richard Nesto, MD
Supported by an educational grant from sanofi-aventis |
12:15pm – 1:30pm
|
LUNCH SYMPOSIUM
Targeting the Pathophysiology of Type 2 Diabetes:
The Emerging Role of Incretin-Based Therapies
Vivian Fonseca, MD; Jack Leahy, MD; Richard Pratley, MD
Supported by an educational grant from Novo Nordisk |
6:30pm – 8:30pm
|
DINNER SYMPOSIUM
Integrated Neurohormonal Therapy:
An Emerging
Approach for Cardiometabolic Risk Reduction
Jeffrey Friedman, MD, PhD; Richard Nesto, MD; Carol Wysham, MD
Supported by an educational grant from Amylin |
Friday, October 17, 2008
6:30am – 7:45am
|
BREAKFAST SYMPOSIUM
Incretin Mimetics and Cardiometabolic Risk Reduction:
Targeting Diabetes, Obesity, Hypertension, and Dyslipidemia
John Buse, MD, PhD, CDE; Byron Hoogwerf, MD; Anne Peters, MD
Supported by an educational grant from Amylin/Lilly |
12:15pm – 1:30pm
|
LUNCH SYMPOSIUM
Are All Beta Blockers Created Equal? The Role of
New Generation Beta Blockade
in the Treatment
of Patients at Increased Cardiometabolic Risk
George Bakris, MD; Thomas Giles, MD; R. Preston Mason, PhD
Supported by an educational grant from Forest Laboratories |
12:15pm – 1:30pm
|
LUNCH SYMPOSIUM
New Options for Preventing Thrombotic Complications in Patients
with Coronary Heart Disease: Novel P2Y12 Antagonists
Eugene Braunwald, MD; Christopher Cannon, MD; Marc Sabatine, MD
Supported by an educational grant from Daiichi-Sankyo/Lilly |
6:30pm – 8:30pm
|
DINNER SYMPOSIUM
Comprehensive Cardiometabolic Risk Reduction:
New Approaches to Targeting
Type 2 Diabetes, Lipids, and Hypertension
George Bakris, MD; Om Ganda, MD; Ronald Goldberg, MD;
Alan Gradman, MD
Supported by an educational grant from Daiichi-Sankyo
|
Saturday, October 18, 2008
6:30am – 7:45am
|
BREAKFAST SYMPOSIUM
From Pipeline to Practice:
The Role of DPP-4 Inhibitors in Achieving Glycemic Control
Richard Pratley, MD; David D’Alessio, MD; Jaime Davidson, MD
Supported by an educational grant from Takeda
|
|
See Who's Attending
Join Our Mailing List
2009 Congress Details
2007 Congress Details
Useful Links
Recommend This Site
